Delivery Order SPE2DB24D2012-SPE2DB25FBVGZ
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.87 firm fixed-price delivery order is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.87 firm fixed-price delivery order is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $3,033.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with an ultimate completion date of January 23, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,188.14, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp Corporate Office Division. The award is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price and the ultimate completion date is August 15, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This federal contract award, valued at $1,263.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award, valued at $2,195.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, and has an ultimate completion date of October 22, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,151.40 firm fixed-price delivery order is for the supply of JATENZO 237 MG CAPSULE 120S, with a period of performance through January 29, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,265.66, is a Delivery Order for the supply of JATENZO 237 MG Capsule 120s, a medical product. The contract has an ultimate completion date of October 23, 2024 and is a Firm Fixed Price contract. This award is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,282.21, is for the delivery of JATENZO 237 MG CAPSULE 120S, a medical product. This contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of JATENZO 237 MG capsules in 120-count packages. The $1,131.87 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...